Immunophenotypic profile of nucleated erythroid progenitors during maturation in regenerating bone marrow

Leukemia and Lymphoma

Volumn 54, Issue 11, 2013, Pages 2523-2530

  Fajtova, Michaela ^a,b   Kovarikova, Anna ^a,b   Svec, Peter ^c   Kankuri, Esko ^d   Sedlak, Jan ^a  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c Physics and Informatics   (Slovakia)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Basophilic erythroblasts; Erythroid development; Immunophenotyping; Nucleated erythroid progenitors; Orthochromatophilic erythroblasts; Polychromatophilic erythroblasts; Pro erythroblasts

Indexed keywords

CD235A ANTIGEN; CD36 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; CD71 ANTIGEN; ENDOGLIN; LYMPHOCYTE ANTIGEN; METHOTREXATE; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL COUNT; CELL REGENERATION; CLINICAL ARTICLE; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL;

ANTIGENS, CD; BONE MARROW CELLS; CELL DIFFERENTIATION; ERYTHROCYTES; ERYTHROID PRECURSOR CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA;

EID: 84885603702     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.781167     Document Type: Article

References (29)

1. Santos PS, Borghesi L. Molecular resolution of the B cell landscape. Curr Opin Immunol 2011;23:163-170.
2. Babusikova 0, Zeleznikova I. Normal maturation sequence of immunoglobulin light and heavy chains in hematogone stages 1, 2 and 3 in acute leukemia after treatment. Neoplasma 2008;55:501-506.
3. Babusikova 0, Zeleznikova I, Kirschnerova G, et al. Hematogones in acute leukemia during and after therapy. Leuk Lymphoma 2008;49:1935-1944.
4. Babusikova 0, Zeleznikova T, Mlcakova A, et al. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia. Neoplasma 2005;52:502-509.
5. Bessis M. Erythroblastic island, functional unity of bone marrow. Rev Hematol 1958;13:8-11.
6. Chasis JA, and N. Erythroblastic islands: Niches for erythropoiesis. Blood 2008;112:470-478.
7. Gregory CT, Eaves AC. Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood 1978;51:527-537.
8. Kondo M, Wagers AL Manz MG, et al. Biology of hematopoietic stem cells and progenitors: Implications for clinical application. Annu Rev Immunol 2003;21:759-806.
9. Weissman IL, Shizuru TA. The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases. Blood 2008;112:3543-3553.
10. Ronzoni L, Bonara P, Rusconi D, et al. Erythroid differentiation and maturation from peripheral CD34 + cells in liquid culture: Cellular and molecular characterization. Blood Cells Mol Dis 2008;40:148-155.
11. Xiuli A, Mohandas N. Erythroblastic islands, terminal erythroid differentiation and reticulocyte maturation. Jpn Soc Hematol 2011;93:139-143.
12. De Jong MO, Wagemaker G, Wogum AW. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit. Blood 1995;86:4076-7085.
13. Wojda U, Leigh KR, Njoroge JM. Fetal haemoglobin modulation during human erythropoiesis: Stem cell factor has late effects related to the expression pattern of CD117. Blood 2003;101:492-497.
14. Bflhring HJ, Muller CA, Letarte M, et al. Endoglin is expressed on subpopulation of immature erythroid cells of normal human bone marrow. Leukemia 1991;5:841-847.
15. Mirabelli P, Di Noto R, Lo Pardo C, et al. Extended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: Implication for erythroid differentiation studies. BMC Physiol 2008;8:13-23.
16. Van Lochem EG, Van Der Velden VHJ, Wind HK, et al. Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: Reference patterns for age-related changes and disease-Induced shifts. Cytometry B Clin Cytom 2004;60:1-13.
17. Wood B. Multicolor immunophenotyping: Human immune system hematopoiesis. In: Darzynkiewicz Z, Roederer M, Tanke HJ, editors. Methods in Cell Biology, Vol. 75. Cytometry. 4th ed. San Diego, CA: Elsevier Academic Press. 2004. pp 559-576.
18. Hasserjian RP, Zuo Z, Garcia C, et al. Acute erythroid leukemia: Reassessment using criteria refined in the 2008 WHO classification. Blood 2010;115:1985-1992.
19. Zuo Z, Polski JM, Kasyan A, et al. Acute erythroid leukemia. Arch Pathol Lab Med 2010;134:1261-1270.
20. Zeleznikova T, Babusikova 0. The value of dot plot patterns and leukemia-associated phenotypes in AML diagnosis by multiparameter flow cytometry. Neoplasma 2005;52:517-522.
21. Manz MG, Miyamoto T, Akashi K, et al. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci USA 2002;99:11872-11877.
22. Fortunel NO, Hatzfeld A, Hatzfeld, JA. Transforming growth factor-j3: Pleiotropic role in the regulation of hematopoiesis. Blood 2000;96:2022-2036.
23. Krystal G, Lam V, Dragowska W, et al. Transforming growth factor beta 1 is an inducer of erythroid differentiation. J Exp Med 1994; 180:85 1-860
24. Chen K, Liu J, Heck 5, et al. Resolving the distinct stages in erythroid differentiation based on dynamic changes in membrane protein expression during erythropoiesis. Proc Natl Acad Sci USA 2009; 106: 17413-17418.
25. Borrione P, Spaccamiglio A, Parisi A, et al. A biparametric flow cytometry analysis for the study of reticulocyte patterns of maturation. Tnt J Lab Hematol 2010;32:65-73.
26. Della Porta MG, Malcovati L, Invernizzi R, et al. Flow cytometry evaluation of erythroid dysplasia in patients with myelodysplastic syndrome. Leukemia 2006;20:549-555.
27. Malcovati L, Della Porta MG, Lunghi M, et al. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 2005;19:776-783.
28. Westers TM, Ireland R, Kern W, et al. Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group. Leukemia 2012;26:1730-1741.
29. Matarraz 5, Lopez A, Barrena 5, et al. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on a series of 56 patients. Cytometry B Clin Cytom 20 10;78: 154-168.